文献速递妇科

产次、不孕、口服避孕药和激素替代治疗与卵巢浆液性交界性肿瘤风险:一项全国性病例对照研究

Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
PubMed 文献 · Gynecol Oncol · 2017-01-17

丹麦1978-2002年全国性病例对照研究,所有卵巢浆液性交界性肿瘤(SBT)经中心病理专家复核,每例匹配15名年龄相仿对照。经产妇SBT风险随子女数增加而降低(p<0.01),不孕(OR=3.31;95%CI:2.44-4.49)、激素替代治疗(HRT)(OR=1.32;95%CI:1.02-1.72)与风险升高相关,口服避孕药(OC)与风险降低相关(OR=0.40;95%CI:0.26-0.62)。

要点

  • 经产妇SBT风险降低,且随子女数增加而进一步降低(p<0.01)。
  • 不孕者SBT风险升高(OR=3.31;95%CI:2.44-4.49),经产妇与未产妇中均存在。
  • OC使用与SBT风险降低相关(OR=0.40;95%CI:0.26-0.62),HRT使用与风险升高相关(OR=1.32;95%CI:1.02-1.72)。

核心结论

  • 产次、不孕、HRT使用和OC使用分别与SBT风险强烈相关,支持SBT与浆液性卵巢癌共享相似危险因素。

研究设计与样本

  • 全国性病例对照研究,纳入丹麦1978-2002年所有诊断为SBT的女性,SBT经中心病理专家复核确认。
  • 每例病例按风险集抽样随机选取15名年龄匹配女性对照;排除既往癌症(非黑色素瘤皮肤癌除外)的病例和对照,以及双侧卵巢切除或输卵管卵巢切除的对照。
  • 采用条件logistic回归估计调整OR和95%CI。

主要发现

  • 经产妇SBT风险强烈降低,且随子女数增加而降低(p<0.01);首次生育年龄较大也降低SBT风险(p=0.03)。
  • 不孕与SBT风险升高相关(OR=3.31;95%CI:2.44-4.49),经产妇和未产妇中均存在。
  • HRT使用与SBT风险升高相关(OR=1.32;95%CI:1.02-1.72);OC使用与SBT风险降低相关(OR=0.40;95%CI:0.26-0.62)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Few studies have examined the risk of an ovarian serous borderline tumor (SBT) associated with parity, infertility, oral contraceptives (OCs), or hormone replacement therapy (HRT), which was the study aim. METHODS: This nationwide case-control study included all women with an SBT diagnosis in Denmark, 1978-2002. SBTs were confirmed by centralized expert pathology review. For each case, 15 age-matched female controls were randomly selected using risk-set sampling. Cases and controls with previous cancer (except for non-melanoma skin cancer) and controls with bilateral oophorectomy or salpingo-oophorectomy were excluded. Conditional logistic regression was used to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: We found a strongly decreased risk of SBTs among parous women which decreased with increasing number of children (p<0.01). Older age at first birth also decreased the SBT risk (p=0.03). An increased SBT risk was associated with infertility (OR=3.31; 95% CI: 2.44-4.49), which was present both among parous and nulliparous women. HRT use increased the SBT risk (OR=1.32; 95% CI: 1.02-1.72), whereas OC use decreased the risk (OR=0.40; 95% CI: 0.26-0.62). CONCLUSIONS: Our nationwide study with expert histopathologic review of all SBTs showed that parity, infertility, use of HRT, and use of OCs, respectively, were strongly associated with the risk of SBTs. This is the first study to report a strong and significantly decreased SBT risk associated with OC use and a significantly increased risk with infertility, and HRT use. This supports that SBTs and serous ovarian cancer share similar risk factors.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Rasmussen ELK, Hannibal CG, Dehlendorff C, et al. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study. Gynecol Oncol. 2017. PMID: 28108026. doi:10.1016/j.ygyno.2017.01.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。